EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)

Delayed Data
As of 3:59pm ET
 +0.27 / +3.27%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 25.00 and a low estimate of 8.50. The median estimate represents a +157.91% increase from the last price of 8.53.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in EyePoint Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.00%
Growthannually 48.82%


Growthquarterly 18.93%
Growthannually 7.68%
Key to the earnings and sales forecast charts.